Cargando…
Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
INTRODUCTION: Cardiovascular benefits observed with new antidiabetic agents may not extend to chronic kidney disease (CKD) patients. This study performed a systematic review and meta-analysis of cardiovascular outcome trials (CVOTs) using new antidiabetic agents stratified by kidney function. METHOD...
Autores principales: | Arshad, Adam, Sarween, Nadia, Sharif, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418973/ https://www.ncbi.nlm.nih.gov/pubmed/34514202 http://dx.doi.org/10.1016/j.ekir.2021.06.029 |
Ejemplares similares
-
Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR”
por: Zhao, Li-Min, et al.
Publicado: (2021) -
Population Estimates of GFR and Risk Factors for CKD in Guatemala
por: Miller, Ann C., et al.
Publicado: (2021) -
Time-dependent risk factors associated with the decline of estimated GFR in CKD patients
por: Chang, Wen-xiu, et al.
Publicado: (2015) -
Combined Albuminuria and Estimated GFR Laboratory Reporting Affects Primary Care Management of CKD
por: Vassalotti, Joseph A., et al.
Publicado: (2020) -
Impact of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) GFR Estimating Equations on CKD Prevalence and Classification Among Asians
por: Betzler, Bjorn Kaijun, et al.
Publicado: (2022)